NCT01174914: Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+ |
|
|
| Completed | 2 | 171 | RoW | ARV's + Placebo, Azidothimidine + lamivudine + nevirapine Or, Stavudine + lamivudine + nevirapine (TRIOMUNE)Or, Azidothimidine + lamivudine + efavirenz Or, Azidothimidine + lamivudine + lopinavir/r Or, Emtricitabine + tenofovir + efavirenz, Naltrexone, Naltrexone + ARV's | The Ojai Foundation | HIV Seropositivity | 03/10 | 03/10 | | |